Become part of the solution for a safer, more humane existence for our beloved horses
The Prisma Difference
Current Imaging Technology
Horse is anesthetized
Potentially dangerous to Horse’s Health
Horse is conscious
No need to use risky anesthesia
Easy and cost effective to implement
A Healthy Size Industry – Why Should We Care?
38 million, or 31% of U.S. households contain a horse enthusiast and the financial impact of the horse industry contributes $122 billion dollars and 1.7 million jobs to the U.S. economy.
Reasons to Invest
Horses are needlessly suffering and experiencing career-ending or even catastrophic, fatal injuries. The life-saving diagnostics that would keep them safe, healthy, and promote a better quality of life, CT imaging, is grossly underutilized because of its cost, difficulty to implement, and is a potential risk to the horse’s health and safety. Prisma’s “game-changing” technology offers a solution that addresses these shortcomings.
Hundreds of horses die every year during training and competition in the U.S.
Total Addressable U.S Equine Market By Segment
Multi-billion market exists for Prisma’s technology
200k Active Racing in US
4 scans/year* @ $1,000/scan
600k Active Showing in US
1 scan/year* @ $1,000/scan
4.7M horses are recreation or other categories in the US.
Worldwide there are 58 million horses @ $1,000/scan
Imagine the Potential
*Number of scans per year based on a horse’s competition and training schedule and medical history
Current Equity Offerings
Prisma currently has a Reg D $4M seed round for which the lead investor is Kirenaga Partners. Prisma’s co-development partner, Triple Ring Technologies, is also an investor in Prisma. There is approximately $1.7 million of preferred shares available in this round which will facilitate the inaugural installation of the system at an equine veterinary clinic and continued development to the system’s commercial readiness.
Prisma’s technical lead and co-development partner is Triple Ring Technologies, one of the industry leaders in developing advanced imaging technology that has the skill sets to execute the system’s final push to commercial readiness. Triple Ring is also an investor in Prisma
Prisma has secured a venture capital investor, Kirenaga Partners. Having investments and being vetted by Kirenaga and Triple Ring, is a great vote of confidence in the viability of achieving commercial success.
We’re in the Home Stretch
Join us in the winner’s circle
To learn more about Prisma and becoming part of our community, please contact us or request our Pitch Deck and offering memorandum.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by Prisma Imaging or any other third party regardless of whether such security, product or service is referenced. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this web site should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance.
Prisma Imaging™ is focused on the development of newly designed radiographic imaging techniques and modalities which will be capable of capturing never-before seen perspectives of the equine and large animal patient.